Related Experiment Video
Updated: Aug 18, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis
Philip G de Groot1, Ronald H M W Derksen
1Department of Haematology, University Medical Center Utrecht, The Netherlands. ph.g.degroot@azu.nl
Purpose Of Review:
The antiphospholipid syndrome is characterized by the paradoxical linkage between thrombosis in vivo and prolongation of clotting times in vitro. Recent reports that are discussed in this overview have taught us that this inconsistency is not so incomprehensible after all.
Recent Findings:
Only a subpopulation of the heterogeneous population of antiphospholipid antibodies is pathogenic. New hypotheses have been proposed to explain the thrombotic tendency in this syndrome. In contrast to what is generally thought, it seems that the increased risk of thrombotic complication is independent of chronic vascular disease.
Summary:
The latest developments could make it possible to define patients with the syndrome unambiguously. This is absolutely necessary to facilitate studies designed to test the current hypotheses on the pathophysiology of antiphospholipid syndrome.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Introduction to Language of Pathophysiology l
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease II: Pathophysiology
